Endothelial progenitor cells: new perspectives and applications in cardiovascular therapies

References

• Risau W, Flamme I. Vasculogenesis. Annu. Rev. Cell Dev. Biol.11, 73–91 (1995).
   PubMed Web of Science ®Google Scholar
• McGrath KE, Koniski AD, Malik J, Palis J. Circulation is established in a stepwise pattern in the mammalian embryo. Blood101(5), 1669–1676 (2003).
   PubMed Web of Science ®Google Scholar
• Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat. Med.6(4), 389–395 (2000).
   PubMed Web of Science ®Google Scholar
• Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science (NY)246(4935), 1306–1309 (1989).
   PubMed Web of Science ®Google Scholar
• Shi Q, Wu MH, Hayashida N et al. Proof of fallout endothelialization of impervious Dacron grafts in the aorta and inferior vena cava of the dog. J. Vasc. Surg.20(4), 546–556; discussion 556–547 (1994).
   PubMed Web of Science ®Google Scholar
• Scott SM, Barth MG, Gaddy LR, Ahl ET Jr. The role of circulating cells in the healing of vascular prostheses. J. Vasc. Surg.19(4), 585–593 (1994).
   PubMed Web of Science ®Google Scholar
• Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science (NY)275(5302), 964–967 (1997).
   PubMed Web of Science ®Google Scholar
• Peichev M, Naiyer AJ, Pereira D et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood95(3), 952–958 (2000).
   PubMed Web of Science ®Google Scholar
• Eichmann A, Corbel C, Nataf V et al. Ligand-dependent development of the endothelial and hemopoietic lineages from embryonic mesodermal cells expressing vascular endothelial growth factor receptor 2. Proc. Natl Acad. Sci. USA94(10), 5141–5146 (1997).
   PubMed Web of Science ®Google Scholar
• Timmermans F, Van Hauwermeiren F, De Smedt M et al. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors. Arterioscler. Thromb. Vasc. Biol.27(7), 1572–1579 (2007).
   PubMed Web of Science ®Google Scholar
• Prater DN, Case J, Ingram DA, Yoder MC. Working hypothesis to redefine endothelial progenitor cells. Leukemia21(6), 1141–1149 (2007).
   PubMed Web of Science ®Google Scholar
• Kalka C, Masuda H, Takahashi T et al. Transplantation of Ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl Acad. Sci. USA97(7), 3422–3427 (2000).
   PubMed Web of Science ®Google Scholar
• Rehman J, Li J, Orschell CM, March KL. Peripheral blood “endothelial progenitor cells” are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation107(8), 1164–1169 (2003).
   PubMed Web of Science ®Google Scholar
• Hur J, Yoon CH, Kim HS et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler. Thromb. Vasc. Biol.24(2), 288–293 (2004).
   PubMed Web of Science ®Google Scholar
• Gulati R, Jevremovic D, Peterson TE et al. Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ. Res.93(11), 1023–1025 (2003).
   PubMed Web of Science ®Google Scholar
• Sieveking DP, Buckle A, Celermajer DS, Ng MK. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. J. Am. Coll. Cardiol.51(6), 660–668 (2008).
   PubMed Web of Science ®Google Scholar
• Lin Y, Weisdorf DJ, Solovey A, Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J. Clin. Invest.105(1), 71–77 (2000).
   PubMed Web of Science ®Google Scholar
• De Meyer SF, Vanhoorelbeke K, Chuah MK et al. Phenotypic correction of von Willebrand disease type 3 blood-derived endothelial cells with lentiviral vectors expressing von Willebrand factor. Blood107(12), 4728–4736 (2006).
   PubMed Web of Science ®Google Scholar
• Shi Q, Rafii S, Wu MH et al. Evidence for circulating bone marrow-derived endothelial cells. Blood92(2), 362–367 (1998).
   PubMed Web of Science ®Google Scholar
• Asahara T, Masuda H, Takahashi T et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res.85(3), 221–228 (1999).
   PubMed Web of Science ®Google Scholar
• Gunsilius E, Duba HC, Petzer AL et al. Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet355(9216), 1688–1691 (2000).
   PubMed Web of Science ®Google Scholar
• Yoder MC, Mead LE, Prater D et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood109(5), 1801–1809 (2007).
   PubMed Web of Science ®Google Scholar
• Aicher A, Rentsch M, Sasaki K et al. Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ. Res.100(4), 581–589 (2007).
   PubMed Web of Science ®Google Scholar
• Hillebrands JL, Klatter FA, van Dijk WD, Rozing J. Bone marrow does not contribute substantially to endothelial-cell replacement in transplant arteriosclerosis. Nat. Med.8(3), 194–195 (2002).
   PubMed Web of Science ®Google Scholar
• Urbich C, Aicher A, Heeschen C et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J. Mol. Cell. Cardiol.39(5), 733–742 (2005).
   PubMed Web of Science ®Google Scholar
• Cho HJ, Lee N, Lee JY et al. Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart. J. Exp. Med.204(13), 3257–3269 (2007).
   PubMed Web of Science ®Google Scholar
• Li Q, Li B, Wang X et al. Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J. Clin. Invest.100(8), 1991–1999 (1997).
   PubMed Web of Science ®Google Scholar
• Nakamura T, Mizuno S, Matsumoto K et al. Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. J. Clin. Invest.106(12), 1511–1519 (2000).
   PubMed Web of Science ®Google Scholar
• Badorff C, Brandes RP, Popp R et al. Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation107(7), 1024–1032 (2003).
   PubMed Web of Science ®Google Scholar
• Koyanagi M, Urbich C, Chavakis E et al. Differentiation of circulating endothelial progenitor cells to a cardiomyogenic phenotype depends on E-cadherin. FEBS Lett.579(27), 6060–6066 (2005).
   PubMed Web of Science ®Google Scholar
• Kawamoto A, Gwon HC, Iwaguro H et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation103(5), 634–637 (2001).
   PubMed Web of Science ®Google Scholar
• Chavakis E, Aicher A, Heeschen C et al. Role of β2-integrins for homing and neovascularization capacity of endothelial progenitor cells. J. Exp. Med.201(1), 63–72 (2005).
   PubMed Web of Science ®Google Scholar
• Yoon CH, Hur J, Park KW et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation112(11), 1618–1627 (2005).
   PubMed Web of Science ®Google Scholar
• Dubois Dubois C, Marsboom G, Depelteau H et al. Intracoronary mesenchymal stem cell or endothelial progenitor cell transfer post myocardial infarction prevents negative remodeling but fails to enhance global functional recovery. J. Am. Coll. Cardiol.55th Annual Scientific Session (Abstract Suppl. 1), 47, A180 (2006).
   Google Scholar
• Gulati R, Jevremovic D, Peterson TE et al. Autologous culture-modified mononuclear cells confer vascular protection after arterial injury. Circulation108(12), 1520–1526 (2003).
   PubMed Web of Science ®Google Scholar
• Werner N, Junk S, Laufs U et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ. Res.93(2), e17–e24 (2003).
   PubMed Web of Science ®Google Scholar
• George J, Afek A, Abashidze A et al. Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice. Arterioscler. Thromb. Vasc. Biol.25(12), 2636–2641 (2005).
   PubMed Web of Science ®Google Scholar
• Nagaya N, Kangawa K, Kanda M et al. Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells. Circulation108(7), 889–895 (2003).
   PubMed Web of Science ®Google Scholar
• Zhao YD, Courtman DW, Deng Y et al. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease. Circ. Res.96(4), 442–450 (2005).
   PubMed Web of Science ®Google Scholar
• Takahashi M, Nakamura T, Toba T et al. Transplantation of endothelial progenitor cells into the lung to alleviate pulmonary hypertension in dogs. Tiss. Eng.10(56), 771–779 (2004).
   PubMedGoogle Scholar
• Marsboom G, Pokreisz P, Gheysens O et al. Sustained endothelial progenitor cell dysfunction after chronic hypoxia-induced pulmonary hypertension. Stem Cells26(4), 1017–1026 (2008).
   PubMed Web of Science ®Google Scholar
• Lyden D, Hattori K, Dias S et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med.7(11), 1194–1201 (2001).
   PubMed Web of Science ®Google Scholar
• Assmus B, Schachinger V, Teupe C et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation106(24), 3009–3017 (2002).
   PubMed Web of Science ®Google Scholar
• Schachinger V, Assmus B, Britten MB et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J. Am. Coll. Cardiol.44(8), 1690–1699 (2004).
   PubMed Web of Science ®Google Scholar
• Bartunek J, Vanderheyden M, Vandekerckhove B et al. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation112(9 Suppl.), I178–I183 (2005).
   PubMed Web of Science ®Google Scholar
• Erbs S, Linke A, Adams V et al. Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study. Circ. Res.97(8), 756–762 (2005).
   PubMed Web of Science ®Google Scholar
• Assmus B, Honold J, Schachinger V et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N. Engl. J. Med.355(12), 1222–1232 (2006).
   PubMed Web of Science ®Google Scholar
• Wang XX, Zhang FR, Shang YP et al. Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial. J. Am. Coll. Cardiol.49(14), 1566–1571 (2007).
   PubMed Web of Science ®Google Scholar
• Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation83(1), 356–362 (1991).
   PubMed Web of Science ®Google Scholar
• Hill JM, Zalos G, Halcox JP et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med.348(7), 593–600 (2003).
   PubMed Web of Science ®Google Scholar
• Vasa M, Fichtlscherer S, Aicher A et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res.89(1), E1–E7 (2001).
   PubMed Web of Science ®Google Scholar
• Werner N, Kosiol S, Schiegl T et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med.353(10), 999–1007 (2005).
   PubMed Web of Science ®Google Scholar
• George J, Herz I, Goldstein E et al. Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis. Arterioscler. Thromb. Vasc. Biol.23(12), e57–e60 (2003).
   PubMed Web of Science ®Google Scholar
• Galasso G, Schiekofer S, Sato K et al. Impaired angiogenesis in glutathione peroxidase-1-deficient mice is associated with endothelial progenitor cell dysfunction. Circ. Res.98(2), 254–261 (2006).
   PubMed Web of Science ®Google Scholar
• Laufs U, Werner N, Link A et al. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation109(2), 220–226 (2004).
   PubMed Web of Science ®Google Scholar
• Rehman J, Li J, Parvathaneni L et al. Exercise acutely increases circulating endothelial progenitor cells and monocyte-/macrophage-derived angiogenic cells. J. Am. Coll. Cardiol.43(12), 2314–2318 (2004).
   PubMed Web of Science ®Google Scholar
• Takahashi T, Kalka C, Masuda H et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med.5(4), 434–438 (1999).
   PubMed Web of Science ®Google Scholar
• Shintani S, Murohara T, Ikeda H et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation103(23), 2776–2779 (2001).
   PubMed Web of Science ®Google Scholar
• Gill M, Dias S, Hattori K et al. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ. Res.88(2), 167–174 (2001).
   PubMed Web of Science ®Google Scholar
• Powell TM, Paul JD, Hill JM et al. Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease. Arterioscler. Thromb. Vasc. Biol.25(2), 296–301 (2005).
   PubMed Web of Science ®Google Scholar
• Cho HJ, Kim HS, Lee MM et al. Mobilized endothelial progenitor cells by granulocyte-macrophage colony-stimulating factor accelerate reendothelialization and reduce vascular inflammation after intravascular radiation. Circulation108(23), 2918–2925 (2003).
   PubMed Web of Science ®Google Scholar
• Hiasa K, Ishibashi M, Ohtani K et al. Gene transfer of stromal cell-derived factor-1α enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Circulation109(20), 2454–2461 (2004).
   PubMed Web of Science ®Google Scholar
• Hattori K, Dias S, Heissig B et al. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J. Exp. Med.193(9), 1005–1014 (2001).
   PubMed Web of Science ®Google Scholar
• Asahara T, Takahashi T, Masuda H et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J.18(14), 3964–3972 (1999).
   PubMed Web of Science ®Google Scholar
• Kalka C, Masuda H, Takahashi T et al. Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ. Res.86(12), 1198–1202 (2000).
   PubMed Web of Science ®Google Scholar
• Heeschen C, Aicher A, Lehmann R et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood102(4), 1340–1346 (2003).
   PubMed Web of Science ®Google Scholar
• Vasa M, Fichtlscherer S, Adler K et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation103(24), 2885–2890 (2001).
   PubMed Web of Science ®Google Scholar
• Walter DH, Rittig K, Bahlmann FH et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation105(25), 3017–3024 (2002).
   PubMed Web of Science ®Google Scholar
• Llevadot J, Murasawa S, Kureishi Y et al. HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells. J. Clin. Invest.108(3), 399–405 (2001).
   PubMed Web of Science ®Google Scholar
• Pistrosch F, Herbrig K, Oelschlaegel U et al. PPARγ-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells. Atherosclerosis183(1), 163–167 (2005).
   PubMed Web of Science ®Google Scholar
• Wang CH, Ting MK, Verma S et al. Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus. Am. Heart J.152(6), 1051 e1–e8 (2006).
   PubMed Web of Science ®Google Scholar
• Min TQ, Zhu CJ, Xiang WX, Hui ZJ, Peng SY; International Society of Cardiovascular Pharmacotherapy. Improvement in endothelial progenitor cells from peripheral blood by ramipril therapy in patients with stable coronary artery disease. Cardiovasc. Drugs Ther.18(3), 203–209 (2004).
   PubMed Web of Science ®Google Scholar
• Thum T, Hoeber S, Froese S et al. Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1. Circ. Res.100(3), 434–443 (2007).
   PubMed Web of Science ®Google Scholar
• Aicher A, Heeschen C, Mildner-Rihm C et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat. Med.9(11), 1370–1376 (2003).
   PubMed Web of Science ®Google Scholar
• Sasaki K, Heeschen C, Aicher A et al.Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy. Proc. Natl Acad. Sci. USA103(39), 14537–14541 (2006).
   PubMed Web of Science ®Google Scholar
• Iwaguro H, Yamaguchi J, Kalka C et al. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation105(6), 732–738 (2002).
   PubMed Web of Science ®Google Scholar
• Wu Y, Ip JE, Huang J et al. Essential role of ICAM-1/CD18 in mediating EPC recruitment, angiogenesis, and repair to the infarcted myocardium. Circ. Res.99(3), 315–322 (2006).
   PubMed Web of Science ®Google Scholar
• Yoon CH, Hur J, Oh IY et al. Intercellular adhesion molecule-1 is upregulated in ischemic muscle, which mediates trafficking of endothelial progenitor cells. Arterioscler. Thromb. Vasc. Biol.26(5), 1066–1072 (2006).
   PubMed Web of Science ®Google Scholar
• Walter DH, Haendeler J, Reinhold J et al. Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ. Res.97(11), 1142–1151 (2005).
   PubMed Web of Science ®Google Scholar
• Yamaguchi J, Kusano KF, Masuo O et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation107(9), 1322–1328 (2003).
   PubMed Web of Science ®Google Scholar
• Ceradini DJ, Kulkarni AR, Callaghan MJ et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med.10(8), 858–864 (2004).
   PubMed Web of Science ®Google Scholar
• Aicher A, Brenner W, Zuhayra M et al. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation107(16), 2134–2139 (2003).
   PubMed Web of Science ®Google Scholar
• DiFabio JM, Thomas GR, Zucco L et al. Nitroglycerin attenuates human endothelial progenitor cell differentiation, function, and survival. J. Pharmacol. Exp. Ther.318(1), 117–123 (2006).
   PubMed Web of Science ®Google Scholar
• Thum T, Fraccarollo D, Schultheiss M et al. Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes, 56(3), 666–674 (2007).
   PubMed Web of Science ®Google Scholar
• Janssens S, Dubois C, Bogaert J et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet367(9505), 113–121 (2006).
   PubMed Web of Science ®Google Scholar
• Schachinger V, Erbs S, Elsasser A et al. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur. Heart J.27(23), 2775–2783 (2006).
   PubMed Web of Science ®Google Scholar
• Lunde K, Solheim S, Aakhus S et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N. Engl. J. Med.355(12), 1199–1209 (2006).
   PubMed Web of Science ®Google Scholar
• Hoetzer GL, Van Guilder GP, Irmiger HM et al. Aging, exercise, and endothelial progenitor cell clonogenic and migratory capacity in men. J. Appl. Physiol.102(3), 847–852 (2007).
   PubMed Web of Science ®Google Scholar
• Loomans CJ, de Koning EJ, Staal FJ et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of Type 1 diabetes. Diabetes53(1), 195–199 (2004).
   PubMed Web of Science ®Google Scholar
• Tepper OM, Galiano RD, Capla JM et al. Human endothelial progenitor cells from Type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation106(22), 2781–2786 (2002).
   PubMed Web of Science ®Google Scholar
• Choi JH, Kim KL, Huh W et al. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler. Thromb. Vasc. Biol.24(7), 1246–1252 (2004).
   PubMed Web of Science ®Google Scholar
• Kondo T, Hayashi M, Takeshita K et al. Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler. Thromb. Vasc. Biol.24(8), 1442–1447 (2004).
   PubMed Web of Science ®Google Scholar